Walgreens EBITDA 2010-2024 | WBA

Walgreens EBITDA for the quarter ending May 31, 2024 was $0.761B, a 325.14% increase year-over-year.

  • Walgreens 2023 EBITDA was -4.372B, a 215.14% decline from 2022.
  • Walgreens 2022 EBITDA was 3.797B, a 19.55% increase from 2021.
  • Walgreens 2021 EBITDA was 3.176B, a 2.28% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Walgreens EBITDA 2010-2024 | WBA

  • Walgreens 2023 EBITDA was -4.372B, a 215.14% decline from 2022.
  • Walgreens 2022 EBITDA was 3.797B, a 19.55% increase from 2021.
  • Walgreens 2021 EBITDA was 3.176B, a 2.28% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
CVS Health (CVS)$73.5B
Herbalife (HLF)$706M
China Jo-Jo Drugstores Holdings (CJJD)$10M
GNC Holdings (GNC)$0M